National Judge Dismisses Suit Alleging Alexandria Misled Investors Over Portfolio Strength Sep 14, 2026 | Matt Wasielewski, National National Capital Markets
Boston Alexandria Scraps Fenway Lab Conversion Plans Jan 28, 2026 | Taylor Driscoll, Boston Boston Life Sciences
National Lawsuit Alleges Alexandria Misled Investors Before Stock Plunged Nov 26, 2025 | Jon Banister, East Coast Editor National Life Sciences
National Biotech Real Estate Behemoth ARE Stumbles Amid Broad Market Uncertainties Apr 29, 2025 | Patrick Sisson, National National Life Sciences
National Alexandria Is 'All In' On Megacampuses With $1.2B Of Asset Sales Pending Oct 22, 2024 | Patrick Sisson, National National Life Sciences
National Alexandria To Push Ahead With Asset Sales, Starting With Former Pfizer HQ Jan 30, 2024 | Molly Armbrister, West Coast Editor National Life Sciences
National REIT Alexandria Names New Co-Presidents, Regional Market Directors Sep 1, 2023 | Taylor Driscoll, Boston National Life Sciences
National Alexandria Swats Away Short Seller Talk As Revenues Rise 11% Jul 25, 2023 | Patrick Sisson, National National Life Sciences
National Peter Moglia To Helm Alexandria Following Resignation Of Co-CEO Jul 26, 2022 | Olivia Lueckemeyer, Dallas-Fort Worth National Life Sciences
Boston Alexandria Pays $168M To Acquire South Boston Development Sites Nov 3, 2020 | Andrew Martinez, Bisnow Boston Boston Life Sciences